Deirdre De Steno is VP, BioPharma Partnerships at PathAI. Deirdre leads a Biopharma Business Development team responsible for building partnerships with biopharma partners in the translational and clinical research space. Prior to PathAI, Deirdre was Sr. Director, Head of Global Medical Affairs for the Diagnostic Business Unit at Grifols. Deirdre’s pre- and post-approval CDx and IVD experience arose from work as a Global Companion Diagnostic Commercialization Director, at both Bristol-Myers Squibb and AstraZeneca. Her work at AstraZeneca helped to accelerate worldwide BRCA/HRD testing across various cancer types, including ovarian, breast, and prostate and thereby increasing access to personalized healthcare for these patients. Deirdre has her PhD from Columbia University, MBA from New York University, and BS from Bucknell University.